Výsledky vyhledávání - "Berenice Baez-Revueltas"

Akademický článek

Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico

Autor: Matthew Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, F. Berenice Baez/Revueltas, Michele Wilson, Cheryl McDade, Raymond Farkouh

Publikováno v: Human Vaccines & Immunotherapeutics, Vol 15, Iss 3, Pp 560-569 (2019)

Introduction: Pneumococcal diseases caused by Streptococcus pneumoniae represent a significant health and economic burden. Mexico has benefited from the inclusion of the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccines (PCV13) since thei

Externí odkaz: https://doaj.org/article/bce77725061b4dd3b159e912c6f0891b

Zobrazit plný text záznamu

A pharmacoeconomic analysis of the collection and preservation of samples in the biobank of the 'Instituto Nacional de Cancerología' in Mexico City

Autor: Ana Laura Colín-González, Virginia Enriquez-Carcamo, Fabiola Berenice Baez-Revueltas, Héctor Maldonado-Martinez, Abelardo Meneses-García, María de Lourdes Suárez-Roa, Luz Ruiz-Godoy

Publikováno v: Cell and Tissue Banking. 19:569-580

In this work we estimated the budgetary impact of the samples produced by the biobank of the "Instituto Nacional de Cancerología" (BT-INCan) to set a recuperation fee from the perspective of the Health Ministry of Mexico. The study is an observation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff113642f0888fc3e1786aace3e1f98d
https://doi.org/10.1007/s10561-018-9706-1

Zobrazit plný text záznamu

Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in Mexico

Autor: Cynthia Villarreal-Garza, Santiago Ruano, Enrique Bargallo-Rocha, Alberto Alvarado-Miranda, Claudia Hs Caro-Sánchez, Alejandro Mohar, Fernando Lara-Medina, Enrique Soto-Perez-de-Celis, Noel Castañeda-Soto, Claudia Arce-Salinas, Erika Sifuentes, Yanin Chavarri-Guerra, Berenice Baez-Revueltas

Publikováno v: The Breast. 24:218-223

Evidence regarding the outcomes of Hispanic women with breast cancer is lacking. We analyzed women with HER2+ disease treated with trastuzumab-based neoadjuvant chemotherapy in Mexico.244 patients were included. Outcomes were compared between patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47084b7446e7f9e80ab9e71dd4efaf8f
https://doi.org/10.1016/j.breast.2015.01.011

Zobrazit plný text záznamu

Platinum-based chemotherapy in triple-negative advanced breast cancer

Autor: Mark Clemons, Daniel Khalaf, Rebecca Dent, Omar Peña-Curiel, Farah Kassam, Berenice Baez-Revueltas, Katherine Enright, Cynthia Villarreal-Garza, Jeff Myers, Nathaniel Bouganim, Sunil Verma, Alexander Kiss, Kathleen I. Pritchard

Publikováno v: Breast Cancer Research and Treatment. 146:567-572

The purpose of this study was to evaluate the efficacy of platinum-based chemotherapy (PBC) versus conventional non-PBC regimens in a metastatic triple-negative breast cancer (TNBC) setting. We reviewed the electronic patient records of patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc8d64ef4be64c3dce9dbf70d6a4ddf
https://doi.org/10.1007/s10549-014-3033-4

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Estimating the Clinical and Economic Impact of Maintaining use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in Mexico

Autor: Cheryl McDade, Raymond Farkouh, Matt Wasserman, Fabiola Berenice Baez Revueltas, Ana Gabriela Grajales, Maria Gabriela Palacios, Michele Wilson

Publikováno v: Open Forum Infectious Diseases

Background PCV13 replaced 7-valent pneumococcal conjugate vaccine in the routine infant immunization schedule in Mexico since 2011. The use of PCV13 has reduced pneumococcal disease incidence for vaccine serotypes, particularly 19A, which emerged fol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e927dd712d85a25bd0e47ee8a755d4e7
http://europepmc.org/articles/PMC5631395

Zobrazit plný text záznamu

Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer

Autor: Daniel Khalaf, Farah Kassam, Mark Clemons, Jeff Myers, Alexander Kiss, Rebecca Dent, Katherine Enright, Cynthia Villarreal-Garza, Berenice Baez-Revueltas, Kathleen I. Pritchard, Nathaniel Bouganim, Omar Peña-Curiel, Sunil Verma

Publikováno v: Breast Cancer Research and Treatment. 150:697-697

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce64702156aebb3af0c58092a3c21168
https://doi.org/10.1007/s10549-015-3345-z

Zobrazit plný text záznamu

Pathologic response and disease-free survival (DFS) after neoadjuvant trastuzumab (T) for HER2+ breast cancer (BC): Results from the National Cancer Institute (NCI) of Mexico

Autor: Erika Sifuentes, Enrique Soto-Perez-de-Celis, Yanin Chavarri Guerra, Cynthia Villarreal-Garza, Jose Antonio Acevedo, F. Berenice Baez-Revueltas, Fernando Lara-Medina, Santiago Ruano

Publikováno v: Journal of Clinical Oncology. 31:e11533-e11533

e11533 Background: The most accurate definition of pathologic complete response (pCR) in HER2+ BC patients (pts) receiving T-based neoadjuvant chemotherapy associated with improved DFS is controversial, particularly regarding the role of residual duc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29cebff8adddf80646ba69dc3f890eb6
https://doi.org/10.1200/jco.2013.31.15_suppl.e11533

Zobrazit plný text záznamu

Predictive factors for pathologic complete response (pCR) to trastuzumab (T)-based neoadjuvant chemotherapy in HER2+ breast cancer (BC) women treated in the National Cancer Institute (NCI) of Mexico

Autor: Enrique Soto-Perez-de-Celis, Santiago Ruano, Yanin Chavarri Guerra, Cynthia Villarreal-Garza, F. Berenice Baez-Revueltas, Fernando Lara-Medina, Erika Sifuentes

Publikováno v: Journal of Clinical Oncology. 31:634-634

634 Background: Neoadjuvant treatment identifies subgroups of patients (pts) with different prognosis. In HER2+ BC, some tumors have been reported to be more sensitive to anti-HER2 therapy than others. We conducted an exploratory analysis in HER2+ BC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7ff12955f8c087a93bf9fe830e28ac2
https://doi.org/10.1200/jco.2013.31.15_suppl.634

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání